May 3 2021 | Globes Panaxia Israel is selling its pharmacy, one of Israel’s largest for cannabis products, to IMC for NIS 20 million. Six months
April 12, 2021 | Market Watch LOD, Israel, April 12, 2021 /PRNewswire/ — The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of
Since November of 2020, any Israeli company wishing to export cannabis has first been required to work with Panaxia.By IDAN ZONSHINE April 15, 2021 | JPost As
Panaxia Israel Laboratories expands into EU marketplace despite challenges posed by year of COVID-19.By MAAYAN JAFFE-HOFFMAN April 5, 2021 | JPost A first shipment of Israeli medical cannabis products
At the end of Q4/2020, Panaxia began commercial exports to Germany, Europe’s largest and fastest-growing cannabis market, and in Q1/2021 was selected and began to
February 3, 2021 | Yahoo! finance Dr. Dadi Segal, CEO of Panaxia Global, said, “We are proud to be collaborating with our neighbor, the government of
January 26, 2021 | Yahoo! finance TEL AVIV, Israel, Jan. 26, 2021 /PRNewswire/ — Dr. Dadi Segal, CEO of Panaxia Global, said, “Our success in this prestigious French government